CDC NEWS


powered by Surfing Waves


Latest News


Pfizer Asks F.D.A. to Authorize Its Covid-19 Vaccine for Children 5 to 11


07 Oct 2021

WASHINGTON — Pfizer and BioNTech said on Thursday morning that they had asked federal regulators to authorize emergency use of their coronavirus vaccine for children ages 5 to 11, a move that could help protect more than 28 million people in the United States.


The Latest on COVID-19 Boosters


28 Sep 2021

More than 180 million Americans, including more than 80 percent of people over age 65, are fully vaccinated against the SARS-CoV-2 virus responsible for COVID-19. There’s no question that full vaccination is the best way to protect yourself against this devastating virus and reduce your chances of developing severe or long-lasting illness if you do get sick. But, to stay ahead of this terrible virus, important questions do remain. A big one right now is: How soon will booster shots be needed and for whom?


FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations


23 Sep 2021

Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for use of a single booster dose, to be administered at least six months after completion of the primary series in: individuals 65 years of age and older; individuals 18 through 64 years of age at high risk of severe COVID-19; and individuals 18 through 64 years of age whose frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of COVID-19 including severe COVID-19


The Most Common COVID-19 Booster Shot Questions, Answered


23 Sep 2021

The Food and Drug Administration has authorized Pfizer COVID-19 booster shots for people over the age of 65 and other at-risk Americans. The agency’s decision was the latest twist in the ongoing debate about when coronavirus booster shots would be necessary — and for whom.


Covid Live Updates: Extra Dose of J. & J. Vaccine Raises Protection, Company Says


21 Sep 2021

In a clinical trial, researchers found that two doses of the vaccine delivered 94 percent efficacy against mild to severe Covid-19.




Articles


U.S. Officials Say Covid-19 Vaccination Effort Has Lagged


30 Dec 2020

The distribution of vaccines in the United States has gotten off to a slower-than-expected start, federal health officials acknowledged in a news conference on Wednesday, though they also voiced confidence that the pace would accelerate in the coming weeks.




Coronavirus Vaccine Tracker


30 Dec 2020

Vaccines typically require years of research and testing before reaching the clinic, but in 2020, scientists embarked on a race to produce safe and effective coronavirus vaccines in record time. Researchers are currently testing 64 vaccines in clinical trials on humans, and 19 have reached the final stages of testing. At least 85 preclinical vaccines are under active investigation in animals.




Help Fight Medicare Fraud


30 Dec 2020

Medicare covers the COVID-19 vaccine at no cost to you, so if anyone asks you to share your Medicare Number or pay for access to the vaccine, you can bet it’s a scam.




Both Remote and On-Site Workers are Grappling with Serious Mental Health Consequences of COVID-19


22 Dec 2020

While millions have recently lost their jobs or income and face new stresses, many who have been during the pandemic also face new pressures.




The lightning-fast quest for COVID vaccines — and what it means for other diseases


18 Dec 2020

The speedy approach used to tackle SARS-CoV-2 could change the future of vaccine science.




Enroll for Free